Maplight Therapeutics, Inc. · NASDAQ:MPLT
T. Rowe Price Investment Management, Inc. reported a 6.20% stake in Maplight Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 17, 2026
T. Rowe Price Investment Management, Inc. reported a 6.20% stake in Maplight Therapeutics, Inc., 2,799,180 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G).
- Stake
- 6.20%
- Shares
- 2,799,180
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 6.20% | 2,799,180 |
Source
Related
- Maplight Therapeutics, Inc.
- T. Rowe Price Investment Management, Inc.
- Maplight Therapeutics, Inc. shareholders
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · May 15, 2026
- Form 4 · Foff Erin Pennock · Oct 16, 2026
- Form 4 · Gillis Jonathan · Oct 16, 2026
- Form 4 · Kroeger Christopher A. · Oct 16, 2026
- Form 4 · Hanson Kristopher · Oct 16, 2026
- Form 4 · Kreitzer Anatol · Oct 16, 2026